Blue Charm builds patient engagement tools that recruit people with specific conditions and valid prescriptions to complete surveys during treatment, compensating participants and delivering medication-adherence insights to pharmaceutical partners. The company plans to enhance product development and expand services for pharma clients by developing advanced data analysis to better understand patient experiences and non-adherence. Blue Charm intends to grow its user base and corporate customer support capabilities and to build a team to attract and support those clients and participants. The company currently employs 14 full-time staff and seven contractors and expects to add 10 staff members by the end of 2026. Founded in 2020 and led by CEO Greg Patey, the business leverages the founder’s prior experience in life sciences and drug-sample distribution. The new funding is intended to support these product and team expansions.

Total raised

$4M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2025